This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Foreman, K. E. Articles by Nickoloff, B. J. Search for Related Content PubMed PubMed Citation Articles by Foreman, K. E. Articles by Nickoloff, B. J.

American Journal of Pathology, Vol 149, 795-803, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Kaposi's sarcoma tumor cells preferentially express Bcl-xL

KE Foreman, T Wrone-Smith, LH Boise, CB Thompson, PJ Polverini, PL Simonian, G Nunez and BJ Nickoloff
Department of Pathology, University of Michigan Medical School, Ann Arbor, USA.

Several recently identified proteins such as Bcl-2 and Bcl-x have been found to regulate programmed cell death (i.e., apoptosis). In this report, we examined the levels of expression of proteins that can either prevent apoptosis (i.e., Bcl-2 or the long form of Bcl-x, designated Bcl-x1) or promote apoptosis (i.e., Bax or the short form of Bcl-x, designated Bcl-xs) in proliferating benign and malignant endothelial cells (ECs). In normal skin with quiescent ECs, no detection by immunohistochemical staining was observed for Bcl-xL, Bcl- xs, or Bcl-2. However, in diseased skin samples that feature a prominent angiogenic response such as in psoriasis or pyogenic granulomas, the proliferating ECs markedly overexpressed Bcl-xL, with little to no Bcl-2. In an acquired-immune-deficiency-syndrome-related neoplasm, Kaposi's sarcoma, the spindle-shaped tumor cells also overexpressed Bcl-xL compared with Bcl-2. These in vivo studies were extended in vitro using cultured ECs and Kaposi's sarcoma tumor cells that were examined by flow cytometry and immunoblot analysis. Both cultured ECs and Kaposi's sarcoma tumor cells express significantly higher levels of Bcl-xL than Bcl-2. Such overexpression of cell survival gene products may contribute to prolonging the longevity of EC- derived cells in several different benign and neoplastic skin disorders that are characterized by a prominent angiogenic tissue response.

This article has been cited by other articles:

				C. Brooks, J. Wang, T. Yang, and Z. Dong Characterization of cell clones isolated from hypoxia-selected renal proximal tubular cells Am J Physiol Renal Physiol, January 1, 2007; 292(1): F243 - F252. [Abstract] [Full Text] [PDF]

				C. Castilla, B. Congregado, D. Chinchon, F. J. Torrubia, M. A. Japon, and C. Saez Bcl-xL Is Overexpressed in Hormone-Resistant Prostate Cancer and Promotes Survival of LNCaP Cells via Interaction with Proapoptotic Bak Endocrinology, October 1, 2006; 147(10): 4960 - 4967. [Abstract] [Full Text] [PDF]

				Z. Dong and J. Wang Hypoxia Selection of Death-resistant Cells: A ROLE FOR Bcl-XL J. Biol. Chem., March 5, 2004; 279(10): 9215 - 9221. [Abstract] [Full Text] [PDF]

				T. Takehara and H. Takahashi Suppression of Bcl-xL Deamidation in Human Hepatocellular Carcinomas Cancer Res., June 15, 2003; 63(12): 3054 - 3057. [Abstract] [Full Text] [PDF]

				J. Tang, G. M. Gordon, M. G. Muller, M. Dahiya, and K. E. Foreman Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells J. Virol., May 15, 2003; 77(10): 5975 - 5984. [Abstract] [Full Text] [PDF]

				M. Mercader, B. Taddeo, J. R. Panella, B. Chandran, B. J. Nickoloff, and K. E. Foreman Induction of HHV-8 Lytic Cycle Replication by Inflammatory Cytokines Produced by HIV-1-Infected T Cells Am. J. Pathol., June 1, 2000; 156(6): 1961 - 1971. [Abstract] [Full Text] [PDF]

				N. Shinoura, Y. Yoshida, M. Nishimura, Y. Muramatsu, A. Asai, T. Kirino, and H. Hamada Expression Level of Bcl-2 Determines Anti- or Proapoptotic Function Cancer Res., August 1, 1999; 59(16): 4119 - 4128. [Abstract] [Full Text] [PDF]

				S. Mori, K. Murakami-Mori, S. Nakamura, A. Ashkenazi, and B. Bonavida Sensitization of AIDS-Kaposi's Sarcoma Cells to Apo-2 Ligand-Induced Apoptosis by Actinomycin D J. Immunol., May 1, 1999; 162(9): 5616 - 5623. [Abstract] [Full Text] [PDF]

				G. Packham, E. L. White, C. M. Eischen, H. Yang, E. Parganas, J. N. Ihle, D. A.M. Grillot, G. P. Zambetti, G. Nuñez, and J. L. Cleveland Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies Genes & Dev., August 15, 1998; 12(16): 2475 - 2487. [Abstract] [Full Text]